inhibitory activity against recombinant hdac6 (BPS Bioscience)
BPS Bioscience is a verified supplier 
BPS Bioscience manufactures this product 
94
Structured Review
BPS Bioscience
inhibitory activity against recombinant hdac6
Inhibitory Activity Against Recombinant Hdac6, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inhibitory+activity+against+recombinant+hdac6/HDAC6+(H611A)%2C+GST-tag+Recombinant/pm40319810-183-12-28
Average 94 stars, based on 6 article reviews
Inhibitory Activity Against Recombinant Hdac6, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inhibitory+activity+against+recombinant+hdac6/HDAC6+(H611A)%2C+GST-tag+Recombinant/pm40319810-183-12-28
Average 94 stars, based on 6 article reviews
inhibitory activity against recombinant hdac6 - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Synthesized:Article Title: Design and synthesis of novel Hydroxamate and non-Hydroxamate HDAC inhibitors based on Chromone and Quinazolone scaffolds. Article Snippet: The development of selective histone deacetylase (HDAC) inhibitors represents an encouraging approach for cancer therapy.. In this study, we report design, synthesis, and biological evaluation of hydroxamate, amidoxime, and carboxylic acid-based derivatives as novel HDAC inhibitors.. The synthesized compounds were assessed for their inhibitory activity against multiple HDAC isoforms, particularly HDAC6, 7, and 8. Activity Assay:Article Title: Design and synthesis of novel Hydroxamate and non-Hydroxamate HDAC inhibitors based on Chromone and Quinazolone scaffolds. Article Snippet: The development of selective histone deacetylase (HDAC) inhibitors represents an encouraging approach for cancer therapy.. In this study, we report design, synthesis, and biological evaluation of hydroxamate, amidoxime, and carboxylic acid-based derivatives as novel HDAC inhibitors.. The synthesized compounds were assessed for their inhibitory activity against multiple HDAC isoforms, particularly HDAC6, 7, and 8. Recombinant:Article Title: Design and synthesis of novel Hydroxamate and non-Hydroxamate HDAC inhibitors based on Chromone and Quinazolone scaffolds. Article Snippet: The development of selective histone deacetylase (HDAC) inhibitors represents an encouraging approach for cancer therapy.. In this study, we report design, synthesis, and biological evaluation of hydroxamate, amidoxime, and carboxylic acid-based derivatives as novel HDAC inhibitors.. The synthesized compounds were assessed for their inhibitory activity against multiple HDAC isoforms, particularly HDAC6, 7, and 8. |